awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38185688-8E6C6823-6E36-4E36-A66E-3300D5C4D958
Q38185688-8E6C6823-6E36-4E36-A66E-3300D5C4D958
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38185688-8E6C6823-6E36-4E36-A66E-3300D5C4D958
Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials.
P2860
Q38185688-8E6C6823-6E36-4E36-A66E-3300D5C4D958
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38185688-8E6C6823-6E36-4E36-A66E-3300D5C4D958
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a3891f2c121dc0d4600d476d50dc95665e689deb
P2860
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression